Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Acceleron Pharma Inc
Acceleron Pharma Inc_20100114
Acceleron Pharma Inc_20100121
  

Acceleron Pharma Inc patents

Recent patent applications related to Acceleron Pharma Inc. Acceleron Pharma Inc is listed as an Agent/Assignee. Note: Acceleron Pharma Inc may have other listings under different names/spellings. We're not affiliated with Acceleron Pharma Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Acceleron Pharma Inc-related inventors




Date Acceleron Pharma Inc patents (updated weekly) - BOOKMARK this page
07/20/17Isolated gdf trap polypeptide
07/06/17Activin-actriia antagonists and uses for treating multiple myeloma
06/01/17Use of activin receptor-like kinase 1 (alk-1) antagonists in the treatment of cancer
05/25/17Activin-actriia antagonists and uses for treating or preventing breast cancer
05/25/17Method of promoting bone growth by an anti-actriia antibody
05/18/17Methods and compositions for treating ineffective erythropoiesis
05/18/17Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof
03/02/17Variants derived from actriib and uses therefor
02/09/17Methods for treating myeloproliferative disorders
01/19/17Actriia binding agents and uses thereof
12/29/16Tgf-beta receptor type ii variants and uses thereof
12/01/16Polynucleotides encoding an actriib antibody
11/10/16Isolated nucleotide sequences encoding gdf traps
11/03/16Methods for treating fatty liver disease
11/03/16Activin-actriia antagonists for inhibiting germ cell maturation
10/27/16Follistatin-related fusion proteins and uses thereof
10/13/16Alk7:actriib heteromultimers and uses thereof
10/13/16Tgf-beta superfamily type i and type ii receptor heteromultimers and uses thereof
10/06/16Compositions and methods for treating pulmonary hypertension
10/06/16Methods for treating myelodysplastic syndromes and sideroblastic anemias
10/06/16Alk4:actriib heteromultimers and uses thereof
10/06/16Single-arm type i and type ii receptor fusion proteins and uses thereof
10/06/16Compositions and methods for treating pulmonary hypertension
09/29/16Methods for dosing an actriib antagonist and monitoring of treated patients
09/29/16Methods for dosing an activin-actriia antagonist and monitoring of treated patients
09/15/16Methods for increasing adiponectin
09/08/16Methods and compositions for treatment of disorders with follistatin polypeptides
07/14/16Methods of promoting fat loss comprising administering an alk7 inhibitor
06/30/16Methods and compositions for treatment of disorders with follistatin polypeptides
06/30/16Truncated actriib-fc fusion protein
05/05/16Method for promoting bone growth using activin-actriia antagonists
04/28/16Cerberus/coco derivatives and uses thereof
04/21/16Actriib-fc polynucleotides, polypeptides, and compositions
02/18/16Methods for increasing red blood cell levels and treating ineffective erythropoiesis
02/11/16Methods and compositions for treating ulcers
12/17/15Methods for increasing red blood cell levels and treating sickle-cell disease
10/22/15Use of activin receptor-like kinase 1 (alk-1) antagonists in the treatment of cancer
09/24/15Bmp-alk3 antagonists and uses for promoting bone growth
07/23/15Endoglin peptides to treat fibrotic diseases
07/02/15Antagonists of activin-actriia and uses for increasing red blood cell levels
07/02/15Compositions and methods for increasing serum half-life
06/11/15Follistatin fusion proteins and uses thereof
02/26/15Tgf-beta receptor type ii variants and uses thereof
02/26/15Methods for increasing adiponectin
01/29/15Actriib binding agents and uses thereof
01/22/15Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
01/08/15Compositions and methods for increasing serum half-life
11/06/14Methods for increasing thermogenic adipocytes
10/23/14Isolated nucleotide sequences encoding gdf traps
08/14/14Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof
07/24/14Methods of promoting fat loss comprising administering an alk7 inhibitor
07/17/14Actriia binding agents and uses thereof
07/10/14Treatment of cancer with alk1 antagonists
03/20/14Method for promoting bone growth using activin-actriia antagonists
12/26/13Alk1 receptor and ligand antagonists and uses thereof
09/19/13Methods and compositions for treating ineffective erythropoiesis
09/19/13Isolated gdf trap polypeptide
08/15/13Cerberus/coco derivatives and uses thereof
08/01/13Activin-actriia antagonists for inhibiting germ cell maturation
07/25/13Actriib binding agents and uses thereof
07/18/13Variants derived from actriib and uses therefor
07/11/13Truncated actriib-fc fusion protein
05/02/13Actriib binding agents and uses thereof
04/25/13Bmp-alk3 antagonists and uses for promoting bone growth
04/04/13Compositions and methods for increasing serum half-life
Patent Packs
03/21/13Methods for increasing red blood cell levels and treating anemia using a combination of gdf traps and erythropoietin receptor activators
03/14/13Actriib-fc polynucleotides, polypeptides, and compositions
02/14/13Methods and compositions for modulating angiogenesis and pericyte composition
02/14/13Methods and compositions for modulating angiogenesis and pericyte composition
01/31/13Cerberus/coco derivatives and uses thereof
01/03/13Activin-actriia antagonists and uses for treating multiple myeloma
08/23/12Bmp10 antibodies and related methods
08/09/12Gdf3 antibodies and related methods
07/19/12Methods of promoting fat loss comprising administering an alk7 inhibitor
06/21/12Methods for increasing adiponectin
06/14/12Methods for increasing thermogenic adipocytes
05/24/12Method of promoting bone growth by an anti-activin antibody
03/08/12Promoting bone growth using activin-actriia antagonists
03/01/12Activin-actrii antagonists and uses for increasing red blood cell levels
01/19/12Use of gdf traps to increase red blood cell levels
Patent Packs
01/05/12Antagonists of actriib and uses for increasing red blood cell levels
09/08/11Activin-actriia antagonists for inhibiting germ cell maturation
07/14/11Compositions and methods for increasing serum half-life
06/09/11Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
06/02/11Methods for treating fatty liver disease
04/21/11Variants derived from actriib and uses therefor
03/24/11Actriib antagonists and dosing and uses thereof
02/24/11Uses of cerberus and derivatives thereof
02/17/11Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
12/23/10Alk7 and myostatin inhibitors and uses thereof
12/16/10Truncated actriib-fc fusion proteins
12/09/10Methods for increasing thermogenic adipocytes
10/21/10Bmp-alk3 antagonists and uses for promoting bone growth
10/21/10Acrtiib-fc polynucleotides, polypeptides, and compositions
08/12/10Activin-actrii antagonists and uses for increasing red blood cell levels
06/24/10Lefty, lefty derivatives and uses thereof
03/18/10Use of gdf traps to increase red blood cell levels
02/04/10Antagonists of activin-actriia and uses for increasing red blood cell levels
02/04/10Antagonists of actriib and uses for increasing red blood cell levels
01/21/10Methods for dosing an activin-actriia antagonist and monitoring of treated patients
01/14/10Methods for dosing an actriib antagonist and monitoring of treated patients
12/17/09Anti-activin antibodies and uses for promoting bone growth
12/17/09Heart20049410 polypeptides and methods of making the same
12/10/09Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof
06/25/09Activin-actrii antagonists and uses for increasing red blood cell levels
06/11/09Bmp10 propeptides and related methods
06/04/09Activin-actriia antagonists and uses for promoting bone growth in cancer patients
05/07/09Activin-actriia antagonists and uses for decreasing or inhibiting fsh secretion
04/16/09Activin-actriia antagonists and uses for promoting bone growth
04/16/09Alk7 and myostatin inhibitors and uses thereof
Social Network Patent Pack
04/16/09Activin-actriia antagonists and uses for promoting bone growth
03/26/09Uses of cerberus, coco and derivatives thereof
03/19/09Activin-actriia antagonists and uses for treating or preventing breast cancer
01/21/10Methods for dosing an activin-actriia antagonist and monitoring of treated patients
01/14/10Methods for dosing an actriib antagonist and monitoring of treated patients







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Acceleron Pharma Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Acceleron Pharma Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';